Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03586635
Other study ID # 18-PP-09
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 13, 2018
Est. completion date September 3, 2021

Study information

Verified date March 2022
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The EDSS score is the reference tool for rating disability in patients with multiple sclerosis. It is used in both daily monitoring and clinical research studies. Its main shortcoming lies in its imprecise and variable nature, with significant inter-examiner variability. This variability is the consequence of the complexity of the score rating and also of its subjective nature. The application developed aims to reduce the risk of rating error, and to homogenize the results obtained regardless of the examiner and his experience in using the score.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date September 3, 2021
Est. primary completion date December 21, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with multiple sclerosis seen at the Central Nervous System Day Hospital as part of their follow-up and requiring neurological examination. - Age = 18 years - No opposition to the use of their data Exclusion Criteria: - Neurological or general pathology, other than multiple sclerosis, that may interfere with EDSS score scoring

Study Design


Related Conditions & MeSH terms


Intervention

Other:
neurological exam
Patients participating in the study are recruited from the investigator's tertiary multiple sclerosis management centre. They are systematically examined neurologically as part of their routine follow-up. the patient will be exceptionally examined by two distinct persons, a senior doctor and a junior doctor (internal or external) independently. At the end of the neurological examination, each examiner will evaluate the EDSS score in a classical way (using paper definitions) then using the smartphone application

Locations

Country Name City State
France Nice University Hospital Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary EDSS score apllication VS paper version comparison of the overall EDSS score obtained with the application and its paper version at the end of the neurological examination 6 months